MedTrace Logo

Non-Invasive Brain Stimulation and Substance Use

NCT03122587 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2020-03-06

Study results available
· View outcomes & findings →

Summary

The will investigate the feasibility and effectiveness and initial efficacy of non-invasive transcranial alternating current stimulation (tACS) on distress tolerance and inhibitory control among treatment seeking substance users.

Conditions

Interventions

DEVICE

Transcranial Alternating Current Stimulation at 10 Hz

Non-invasive, safe transcranial alternating current stimulation administered at 10 Hz to target alpha oscillatory activity

DEVICE

Transcranial Alternating Current Stimulation at 40 Hz

Non-invasive, safe transcranial alternating current stimulation administered at 40 Hz to target gamma oscillatory activity

DEVICE

Active sham transcranial alternating current stimulation

Active sham (placebo)

Sponsors & Collaborators

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Stacey B Daughters, PhD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2019-02-01
Completion
2019-02-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03122587 on ClinicalTrials.gov